Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$386,879.

  • Cumberland Pharmaceuticals' Cash from Financing Activities rose 27.93% to -$386,879 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 8539.54%. This contributed to the annual value of $196,904 for FY2024, which is 102.65% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Cash from Financing Activities of -$386,879 as of Q3 2025, which was down 156.56% from -$150,797 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Cash from Financing Activities ranged from a high of $3.9 million in Q1 2022 and a low of -$5.5 million during Q1 2025.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$882,596 (2023), whereas its average is -$1.2 million.
  • Examining YoY changes over the last 5 years, Cumberland Pharmaceuticals' Cash from Financing Activities showed a top increase of 401.86% in 2022 and a maximum decrease of 619.86% in 2022.
  • Cumberland Pharmaceuticals' Cash from Financing Activities (Quarterly) stood at -$735,300 in 2021, then plummeted by 278.19% to -$2.8 million in 2022, then surged by 46.52% to -$1.5 million in 2023, then climbed by 7.31% to -$1.4 million in 2024, then climbed by 27.93% to -$386,879 in 2025.
  • Its last three reported values are -$386,879 in Q3 2025, -$150,797 for Q2 2025, and -$5.5 million during Q1 2025.